PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1269688
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1269688
Global Healthcare Predictive Analytics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Healthcare predictive analytics is a technique of analyzing historical healthcare data to spot patterns and trends that are likely to predictive of future events. It is generally used to identify medication regimens, optimal treatment plans, and engagement material, along with assessing the disease progression and expected comorbidities. The emergence of personalized and evidence-based medicine, the growing need to curtail healthcare costs by reducing unnecessary costs, and rising government initiatives to increase EHR adoption are the key factors that are fostering the market demand across the globe.
The increasing healthcare expenditure is further attributed to the market growth during the estimated period. The Canadian Institute of Health Information reported in 2021 that Canadian health spending increased to USD 308.1 billion in 2021 compared to USD 301.5 billion in 2020. Similarly, according to the Centers for Medicare and Medicaid Services (CMS) estimates, the United States spent nearly USD 4.3 trillion on health care in 2022, up about USD 173 billion from the year 2021. Thus, the rising healthcare spending is leveraging the market expansion at a considerable rate. Moreover, rising investment in the development of advanced technology, as well as the growing emphasis on increasing efficiency across the healthcare sector is presenting various lucrative opportunities over the forecasting years. However, the dearth of skilled IT professionals in healthcare and the lack of robust infrastructure is hindering the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Healthcare Predictive Analytics Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing adoption of personalized medicine, along with the rising government initiatives in the region. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the development of the healthcare infrastructure, as well as the rising number of chronic disease cases in the regional market.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable